Fund shareholders of Kymera Therapeutics Inc
ISIN US5015751044 · United States
- Fund shareholders
- 328
- Of which ETFs
- 56 272 other funds
- Value held
- 3.2B $ 14.3M SEK
- Share of capital
- 45.0 % of 83.2M shares on Jul 31, 2026
328 funds hold this company. This table lists the 327 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 7,542 | 689K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Global X Guru Index ETF GLOBAL X FUNDS | 7,506 | 608.5K $ | 1.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| NYLI WMC Small Companies Fund NEW YORK LIFE INVESTMENTS FUNDS TRUST | 7,477 | 606.2K $ | 0.19 % | 0.01 % | as of Apr 30, 2026 ↗ |
| WCM Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST | 7,095 | 590.9K $ | 1.26 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 7,000 | 583K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| BlackRock Small Cap Index V.I. Fund BlackRock Variable Series Funds, Inc. | 6,934 | 577.5K $ | 0.16 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 6,839 | 569.6K $ | 0.16 % | 0.01 % | as of Mar 31, 2026 ↗ |
| First Trust Multi Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 6,792 | 550.6K $ | 0.11 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 6,347 | 528.6K $ | 0.56 % | 0.01 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 6,312 | 525.7K $ | 0.26 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Voya RussellTM Small Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 6,221 | 518.1K $ | 0.16 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 6,158 | 499.2K $ | 0.14 % | 0.01 % | as of Apr 30, 2026 ↗ |
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 6,039 | 503K $ | 0.48 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Balanced K6 Fund Fidelity Puritan Trust | 5,900 | 539K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 5,854 | 487.6K $ | 0.09 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AQR Small Cap Momentum Style Fund AQR Funds | 5,698 | 474.6K $ | 0.28 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 5,686 | 473.6K $ | 1.13 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 5,636 | 469.4K $ | 0.31 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Driehaus Small/Mid Cap Growth Fund Driehaus Mutual Funds | 5,446 | 453.6K $ | 0.50 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 5,342 | 444.9K $ | 1.13 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Total Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 5,336 | 444.4K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 4,935 | 450.8K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 4,841 | 403.2K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| MFS Blended Research Small Cap Equity Portfolio MFS VARIABLE INSURANCE TRUST III | 4,762 | 396.6K $ | 0.51 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4,700 | 391.5K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap Value ETF iShares Trust | 4,693 | 380.5K $ | 0.06 % | 0.01 % | as of Apr 30, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 4,663 | 388.4K $ | 0.15 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Fidelity Institutional AM Large Cap Portfolio EQ Advisors Trust | 4,600 | 383.1K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 4,537 | 367.8K $ | 0.14 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 4,528 | 413.6K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 4,293 | 357.6K $ | 0.16 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 4,256 | 354.5K $ | 0.73 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 4,250 | 354K $ | 0.31 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 4,219 | 342K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 4,139 | 344.7K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 4,067 | 371.5K $ | 0.49 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 4,065 | 338.6K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 3,986 | 332K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 3,842 | 351K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 3,765 | 305.2K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AVIP BlackRock Advantage Small Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 3,625 | 301.9K $ | 0.25 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 3,584 | 298.5K $ | 0.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF Goldman Sachs ETF Trust | 3,533 | 322.7K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 3,501 | 283.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 3,491 | 318.9K $ | 0.11 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 3,480 | 317.9K $ | 0.09 % | 0.00 % | as of Feb 28, 2026 ↗ |
| JNL/Mellon U.S. Stock Market Index Fund JNL Series Trust | 3,422 | 285K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Venerable US Small Cap Fund Venerable Variable Insurance Trust | 3,348 | 278.9K $ | 0.20 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc. | 3,336 | 277.9K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 3,322 | 303.5K $ | 0.33 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 3,245 | 270.3K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| First Trust Multi-Manager Small Cap Opportunities ETF First Trust Exchange-Traded Fund VIII | 3,091 | 282.4K $ | 0.62 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 3,077 | 249.5K $ | 0.67 % | 0.00 % | as of Apr 30, 2026 ↗ |
| FlexShares Morningstar US Market Factor Tilt Index Fund FlexShares Trust | 2,916 | 236.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Putnam VT Small Cap Growth Fund Putnam Variable Trust | 2,865 | 238.6K $ | 0.64 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 2,801 | 233.3K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 2,715 | 248K $ | 0.09 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 2,444 | 223.3K $ | 0.14 % | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Capital Appreciation and Income Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 2,435 | 202.8K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 2,375 | 192.5K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 2,365 | 216K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 2,252 | 182.6K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Capital Appreciation Portfolio PACIFIC SELECT FUND | 2,249 | 187.3K $ | 0.18 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PRAXIS SMALL CAP INDEX FUND Praxis Mutual Funds | 2,181 | 181.7K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust | 2,147 | 174.1K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Tax-Efficient Equity Fund T. ROWE PRICE TAX-EFFICIENT FUNDS, INC. | 2,000 | 182.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| BNY Mellon US Small Cap Core Equity ETF BNY Mellon ETF Trust | 1,938 | 157.1K $ | 0.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,830 | 152.4K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 1,804 | 150.3K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AVIP AB Mid Cap Core Portfolio AuguStar Variable Insurance Products Fund Inc | 1,772 | 147.6K $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| First Trust Nasdaq Pharmaceuticals ETF First Trust Exchange-Traded Fund VI | 1,663 | 138.5K $ | 0.47 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,500 | 124.9K $ | 0.16 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 1,500 | 124.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1,497 | 124.7K $ | 0.62 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 1,488 | 123.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,451 | 120.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 1,388 | 115.6K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell Investments U.S. Small Cap Equity ETF Russell Investments Exchange Traded Funds | 1,383 | 115.2K $ | 0.23 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,350 | 112.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 1,280 | 103.8K $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Global Allocation Fund T. ROWE PRICE GLOBAL ALLOCATION FUND, INC. | 1,237 | 100.3K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 1,228 | 102.3K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,216 | 98.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 1,190 | 99.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Tax-Aware Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 1,179 | 98.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 1,143 | 95.2K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,137 | 94.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,136 | 92.1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 979 | 79.4K $ | 0.31 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 977 | 81.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 969 | 80.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 929 | 77.4K $ | 0.73 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 916 | 76.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 675 | 54.7K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 673 | 56.1K $ | 0.37 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 647 | 52.5K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 584 | 48.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 544 | 49.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 540 | 49.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 534 | 44.5K $ | 2.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 4.66 % | as of Feb 28, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 3.28 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 2.08 % | as of Mar 31, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 1.76 % | as of Apr 30, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 1.74 % | as of Apr 30, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.50 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.46 % | as of Apr 30, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 1.39 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 1.35 % | as of Feb 27, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 1.27 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 326 | +46 | 37,368,607 | +19.2 % |
| 2026Q1 | 280 | +34 | 31,349,132 | +16.0 % |
| 2025Q4 | 246 | +17 | 27,025,402 | +2.7 % |
| 2025Q3 | 229 | +20 | 26,320,167 | +5.4 % |
| 2025Q2 | 209 | -17 | 24,978,847 | +3.3 % |
| 2025Q1 | 226 | -3 | 24,181,745 | -0.4 % |
| 2024Q4 | 229 | +7 | 24,277,044 | +9.0 % |
| 2024Q3 | 222 | +8 | 22,274,447 | -1.1 % |
| 2024Q2 | 214 | +9 | 22,529,228 | +36.8 % |
| 2024Q1 | 205 | -9 | 16,467,458 | -17.7 % |
| 2023Q4 | 214 | 20,020,316 |
Institutional managers
248 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 11,699,950 | 974.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 8,657,242 | 721.1M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 7,474,747 | 622.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6,060,847 | 504.8K $ | as of Mar 31, 2026 |
| BVF INC/IL | 5,502,710 | 458.3M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,464,997 | 455.2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,060,876 | 421.5M $ | as of Mar 31, 2026 |
| Atlas Venture Life Science Advisors, LLC | 4,578,008 | 381.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,889,687 | 324M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 3,186,830 | 265.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,389,767 | 199M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 1,673,275 | 139.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,645,350 | 137.1M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 1,043,583 | 86.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,023,852 | 85.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 888,409 | 74M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 888,035 | 69.1M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 875,872 | 73M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 836,759 | 69.7M $ | as of Mar 31, 2026 |
| Merck & Co., Inc. | 772,165 | 64.3M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 759,848 | 63.3M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 750,000 | 62.5M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 626,925 | 52.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 592,879 | 49.4M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 561,170 | 46.7M $ | as of Mar 31, 2026 |
Declared shareholders of Kymera Therapeutics Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 14.30 % | 11,681,450 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Investment Management, Inc. | 6.70 % | 5,460,257 | as of Mar 31, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 10 others | 6.30 % | 5,237,151 | as of Jun 26, 2026 · SCHEDULE 13D |
| Wellington Management Group LLP and 2 others | 4.80 % | 3,889,687 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Kymera Therapeutics Inc". https://titelia.com/en/stocks/kymera-therapeutics-inc-US5015751044